Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Loperamide/Simethicone Caplet vs Imodium Express + Espumisan
NCT04186936Phase 1Completed
- Sponsor
- McNeil Laboratories
- Start
- Dec 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of loperamide and simethicone in diarrhea (2 arms), sponsored by McNeil Laboratories. Primary endpoints: Maximum Observed Concentration at 72 hours and Area Under the Plasma Concentration-time Curve From Time Zero to Time 't' at 72 hours. Started Dec 2019; status: completed.
02
Drugs
loperamidesimethicone
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT04186936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04186936.